In Vivo Activated T Lymphocytes in the Peripheral Blood and Cerebrospinal Fluid of Patients with Multiple Sclerosis

  • Hafler D
  • Fox D
  • Manning M
  • et al.
274Citations
Citations of this article
32Readers
Mendeley users who have this article in their library.
Get full text

Abstract

We found an increase in peripheral-blood lymphocytes bearing the T-cell–specific activation antigen Ta1 in 20 of 35 patients with progressive multiple sclerosis, 4 of 18 patients with stable or improving multiple sclerosis, 1 of 17 patients with other neurologic diseases, and 1 of 14 normal controls (P<0.0002, Fisher's exact test). No increases in two other markers of T-cell activation, T113 and the interleukin-2 receptor, were found. In the cerebrospinal fluid, patients with progressive multiple sclerosis (pleocytosis, 3.9±1.6 cells per cubic millimeter) had 42±3.0 per cent Ta1+ cells. In contrast, patients with other inflammatory central nervous system diseases (36±13 cells per cubic millimeter) had 9.6±1.8 per cent Ta1+ cells (P<0.01). In patients with other neurologic diseases without inflammation (0.7±0.16 cells per cubic millimeter), the percentage of Ta1+ cells was equivalent to that in patients with multiple sclerosis (39±5.4 per cent), although the absolute number was lower. There was a positive correlation between the presence of Ta1+ cells in the spinal fluid and blood of patients with other neurologic diseases, but not patients with multiple sclerosis. Less than 1 per cent of lymphocytes from the spinal fluid of patients with multiple sclerosis expressed interleukin-2 receptors, as compared with 9.8 per cent of cells from subjects with other inflammatory neurologic diseases (P<0.01). These results suggest that the T cells in the spinal fluid of patients with multiple sclerosis may be activated by a different mechanism or in a different temporal sequence from that in patients with other nervous system diseases. Furthermore, the increase in Ta1+ cells in the peripheral blood of patients with multiple sclerosis demonstrates systemic immune activation in the disease; monitoring such cells may provide an objective measure of abnormal immunologic activity. (N Engl J Med 1985; 312: 1405–11.). © 1985, Massachusetts Medical Society. All rights reserved.

Cite

CITATION STYLE

APA

Hafler, D. A., Fox, D. A., Manning, M. E., Schlossman, S. F., Reinherz, E. L., & Weiner, H. L. (1985). In Vivo Activated T Lymphocytes in the Peripheral Blood and Cerebrospinal Fluid of Patients with Multiple Sclerosis. New England Journal of Medicine, 312(22), 1405–1411. https://doi.org/10.1056/nejm198505303122201

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free